Tilray Brands (NASDAQ: TLRY) stock skyrocketed this morning, surging 25% by 10:15 a.m. ET, with even more significant gains in the early hours. The reason behind this surge can be attributed to President Trump’s potential move to legalize marijuana, as reported by The Washington Post.
While it’s not officially confirmed yet, the Post cited six sources indicating that President Trump may issue an executive order in January to reclassify marijuana as a Schedule III drug, moving it away from the more restrictive Schedule I classification. This change would align the regulation of marijuana more closely with that of common prescription painkillers, making it easier for banks to provide services to marijuana companies and reducing tax obligations for businesses in the industry.
For Tilray stock specifically, any relaxation of marijuana regulations would likely increase demand for the product, potentially boosting sales and profits for the company. However, it’s essential to note that despite marijuana being legal in Tilray’s home market of Canada, the company has struggled to turn a profit since 2018.
While the rescheduling of marijuana in the U.S. could have a positive impact on Tilray’s financial performance, there are no guarantees. Before investing in Tilray Brands, it’s crucial to consider all factors carefully.
It’s worth noting that the Motley Fool Stock Advisor analyst team recently identified the 10 best stocks for investors to buy now, and Tilray Brands did not make the list. The stocks recommended by the team have the potential to generate significant returns in the future, as demonstrated by past recommendations such as Netflix and Nvidia, which saw substantial growth following their inclusion in the list.
Investors should conduct thorough research and consider all available information before making any investment decisions, especially in a volatile and evolving industry like marijuana.
